<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01790061</url>
  </required_header>
  <id_info>
    <org_study_id>FMT-CN-121123</org_study_id>
    <nct_id>NCT01790061</nct_id>
  </id_info>
  <brief_title>Standardized Fecal Microbiota Transplantation for Ulcerative Colitis</brief_title>
  <official_title>Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Second Hospital of Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The gut microbiota is considered to constitute a &quot;microbial organ&quot; which has pivotal roles in
      the intestinal diseases and body's metabolism. Evidence from animal and human studies
      strongly supports the link between intestinal bacteria and inflammatory bowel diseases (IBD).
      Dozens of studies reported its efficacy in treatment of severe Clostridium difficile colitis.
      Preliminary studies using FMT for Ulcerative Colitis (UC), Crohn's diseases, irritable bowel
      syndrome (IBS) and constipation have also met with some success. This is an initial step into
      investigating the potential efficacy of standardized fecal bacteriotherapy through mid-gut
      (at least below duodenal papilla) for UC, the investigators propose to determine the
      efficiency and safety of FMT in a series of 500 patients with moderate to severe UC (Montreal
      classification).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present clinical trial aims to re-establish a gut functionality state of intestinal
      microbiota through FMT as a therapy for UC. Investigators established a standard bacteria
      isolation from donated fresh stool in lab. Then the bacteria is transplanted to mid-gut
      through regular gastroscope. Patients in this study will assigned to receive FMT(s) or
      traditional treatments according to associated guidelines and follow-up for long term. All
      data were recorded in China Microbiota Transplantation System.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2032</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of FMT</measure>
    <time_frame>On year</time_frame>
    <description>The efficacy and durability of clinical remission (days) after Fecal Microbiota Transplantation procedure.Defined as Montreal score S0 (clinical remission)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Ten years</time_frame>
    <description>Number and severity of adverse events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Bacteria</condition>
  <condition>Microbiota</condition>
  <condition>Fecal Microbiota Transplantation</condition>
  <condition>Inflammatory Bowel Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Standardized FMT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endoscopy Tubing Once or repeat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional treatments</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral Tubing</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standardized FMT</intervention_name>
    <description>Fecal microbiota transplantation by gastroscopy administration of fresh or frozen bacteria from healthy donor to the mid-gut or whole colon</description>
    <arm_group_label>Standardized FMT</arm_group_label>
    <other_name>Fecal Microbiota Transplantation</other_name>
    <other_name>Fecal Microbiota Therapy</other_name>
    <other_name>fecal transplantation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traditional treatments</intervention_name>
    <description>Medications</description>
    <arm_group_label>Traditional treatments</arm_group_label>
    <other_name>Traditional treatments according to associated guidelines</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Moderate to serious UC (Montreal classification)

        Exclusion Criteria:

        Diagnosed as UC first time. No history of using Biologic,immunomodulatory therapy or
        corticosteroid therapy.

        With contraindication of endoscopy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huijie Zhang, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The Second Afiliated Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faming Zhang, MD,PhD</last_name>
    <phone>086-25-58509883</phone>
    <email>fzhang@njmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Faming Zhang, MD,PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faming Zhang, MD, PhD</last_name>
      <phone>086-25-58509883</phone>
      <email>fzhang@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>Fecal microbiota transplantation</description>
  </link>
  <reference>
    <citation>Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011 Dec 20;9(2):88-96. doi: 10.1038/nrgastro.2011.244. Review.</citation>
    <PMID>22183182</PMID>
  </reference>
  <reference>
    <citation>Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013 Jan;29(1):79-84. doi: 10.1097/MOG.0b013e32835a4b3e. Review.</citation>
    <PMID>23041678</PMID>
  </reference>
  <reference>
    <citation>Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012 Nov;107(11):1755; author reply p.1755-6. doi: 10.1038/ajg.2012.251.</citation>
    <PMID>23160295</PMID>
  </reference>
  <reference>
    <citation>Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989 Jan 21;1(8630):164.</citation>
    <PMID>2563083</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2013</study_first_submitted>
  <study_first_submitted_qc>February 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2013</study_first_posted>
  <last_update_submitted>January 7, 2018</last_update_submitted>
  <last_update_submitted_qc>January 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Faming Zhang</investigator_full_name>
    <investigator_title>Associate professor, Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Gut bacteria</keyword>
  <keyword>Gut flora</keyword>
  <keyword>Bacteriotherapy</keyword>
  <keyword>Fecal Microbiota Transplantation</keyword>
  <keyword>Inflammatory bowel disease</keyword>
  <keyword>Ulcerative colitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

